Literature DB >> 12740832

Split genes and their expression in Kaposi's sarcoma-associated herpesvirus.

Zhi-Ming Zheng1.   

Abstract

A split or interrupted gene is defined as a gene consisting of introns and exons. Removal (splicing) of the intron(s) from a primary transcript (pre-mRNA) is essential for creating a mRNA. Initial assignment of a potential protein coding region in the KSHV genome was based on the initiation codon context and predicted protein size larger than 100 amino acids, but the gene discontinuity was disregarded. Experimental investigation of the assigned ORFs has demonstrated that there are up to 25 split genes, more than one fourth of the total KSHV genes described in the KSHV genome. This includes the genes involved in all phases (latent, immediate early, early and late) of KSHV infection. The complexity of a split gene expression depends upon the availability of a proximal promoter and polyadenylation (pA) signal. Sharing a single promoter or a single pA signal by two or three genes is not uncommon in the expression of KSHV split genes and the resulting transcripts are usually polycistronic. Among those of KSHV split genes, 15 genes express a bicistronic or tricistronic RNA and 10 genes express a monocistronic RNA. Alternative RNA splicing could happen in a particular pre-mRNA due to intron or exon inclusion or skipping or the presence of an alternative 5' splice site or 3' splice site. This may, respectively, result in at least 8 species of K8 and 14 species of K15 transcripts. This appears to be related to cell differentiation and stages of the virus infection, presumably involving viral cis elements and trans splicing factors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12740832      PMCID: PMC4681429          DOI: 10.1002/rmv.387

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  103 in total

1.  Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma.

Authors:  P Rimessi; A Bonaccorsi; M Stürzl; M Fabris; E Brocca-Cofano; A Caputo; G Melucci-Vigo; M Falchi; A Cafaro; E Cassai; B Ensoli; P Monini
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

2.  The pre-mRNA 5' cap determines whether U6 small nuclear RNA succeeds U1 small nuclear ribonucleoprotein particle at 5' splice sites.

Authors:  L O'Mullane; I C Eperon
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

3.  The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter.

Authors:  Hong Li; Takashi Komatsu; Bruce J Dezube; Kenneth M Kaye
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

4.  The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression.

Authors:  A K Gupta; V Ruvolo; C Patterson; S Swaminathan
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

Review 6.  Molecular virology of Kaposi's sarcoma-associated herpesvirus.

Authors:  P S Moore; Y Chang
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-04-29       Impact factor: 6.237

7.  Kaposi's sarcoma-associated herpesvirus encodes a bZIP protein with homology to BZLF1 of Epstein-Barr virus.

Authors:  S F Lin; D R Robinson; G Miller; H J Kung
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

8.  The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1.

Authors:  M S Raab; J C Albrecht; A Birkmann; S Yağuboğlu; D Lang; B Fleckenstein; F Neipel
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon.

Authors:  F Del Gatto; R Breathnach
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

10.  Isolation and characterization of a low-abundance splice variant from the human cytomegalovirus major immediate-early gene region.

Authors:  J A Kerry; A Sehgal; S W Barlow; V J Cavanaugh; K Fish; J A Nelson; R M Stenberg
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  29 in total

1.  Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster.

Authors:  Muzammel Haque; Victoria Wang; David A Davis; Zhi-Ming Zheng; Robert Yarchoan
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

2.  A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus.

Authors:  Thomas J Ellison; Yoshihiro Izumiya; Chie Izumiya; Paul A Luciw; Hsing-Jien Kung
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

3.  Delineation of a core RNA element required for Kaposi's sarcoma-associated herpesvirus ORF57 binding and activity.

Authors:  Emi Sei; Nicholas K Conrad
Journal:  Virology       Date:  2011-09-01       Impact factor: 3.616

4.  Kaposi's Sarcoma-Associated Herpesvirus Utilizes and Manipulates RNA N6-Adenosine Methylation To Promote Lytic Replication.

Authors:  Fengchun Ye; E Ricky Chen; Timothy W Nilsen
Journal:  J Virol       Date:  2017-07-27       Impact factor: 5.103

5.  Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Jason M Schifano; Kathleen Corcoran; Hemant Kelkar; Dirk P Dittmer
Journal:  J Virol       Date:  2017-01-31       Impact factor: 5.103

6.  Kaposi's sarcoma-associated herpesvirus K8beta is derived from a spliced intermediate of K8 pre-mRNA and antagonizes K8alpha (K-bZIP) to induce p21 and p53 and blocks K8alpha-CDK2 interaction.

Authors:  Koji Yamanegi; Shuang Tang; Zhi-Ming Zheng
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59.

Authors:  Vladimir Majerciak; Koji Yamanegi; Zhi-Ming Zheng
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

8.  Kaposi's sarcoma-associated herpesvirus ORF57 protein binds and protects a nuclear noncoding RNA from cellular RNA decay pathways.

Authors:  Brooke B Sahin; Denish Patel; Nicholas K Conrad
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

9.  Molecular characterization of the rhesus rhadinovirus (RRV) ORF4 gene and the RRV complement control protein it encodes.

Authors:  Linda Mark; O Brad Spiller; Marcin Okroj; Simon Chanas; Jim A Aitken; Scott W Wong; Blossom Damania; Anna M Blom; David J Blackbourn
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

10.  Binding of Kaposi's sarcoma-associated herpesvirus K-bZIP to interferon-responsive factor 3 elements modulates antiviral gene expression.

Authors:  Sylvain Lefort; Anton Soucy-Faulkner; Nathalie Grandvaux; Louis Flamand
Journal:  J Virol       Date:  2007-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.